相关实验视频
Updated: May 2, 2026
06:03
Delivery of Modified mRNA in a Myocardial Infarction Mouse Model
Published on: June 11, 2020
9.0K
通过减弱炎症反应,转化暂时抑制改善心脏功能
Christoph Hofmann1,2,3, Adrian Serafin1,2, Ole M Schwerdt1,2
1Department of Internal Medicine III (Cardiology, Angiology, and Pneumology [C.H., A.S., O.M.S., J.F., F. Sicklinger, F.S.Y., I.S.M., E.M., C. Sandmann, L.J., V.K.-S., C. Stroh, Z.L., D.F., E.B., H.A.K., N.F., F.L., M.V.]), Heidelberg University Hospital, Germany.
Circulation
|August 29, 2024
概括
缺血/再输伤 (I/ R) 通过mTORC1/ eIF4F途径激活mRNA翻译,导致心脏炎症. 抑制这种途径可以减少炎症并改善心肌梗塞后的心脏功能.
科学领域:
- 心血管生物学
- 分子医学
- 翻译研究
背景情况:
- 心肌缺血/再注血 (I/R) 损伤引发适应性基因表达变化.
- mRNA转化是基因表达的关键调节者,但其在I/R诱导的心脏炎症中的作用尚不清楚.
- 了解I/R中的转化控制对于开发向疗法至关重要.
研究的目的:
- 研究mRNA翻译在心脏基因表达和I/R后的炎症中的作用.
- 探索应对I/R的转换控制机制.
- 评估针对mRNA转化减轻I/R损伤的治疗潜力.
主要方法:
- 在再注血后测量体外和体外蛋白质合成.
- 使用药理和遗传方法来准翻译启动.
- 进行心肌细胞特异性核糖体分析以分析mRNA转化.
- 在抑制翻译后量化免疫细胞透和炎症基因表达.
主要成果:
- 通过mTORC1- EBP1- eIF4F轴迅速恢复并超过了基线转化活性.
- 在心脏炎症和单细胞透中,I/ R增加了mRNA网络的翻译.
- 抑制mTORC1-4EBP1-eIF4F轴减少了前炎性细胞因子表达和Ly6Chi单细胞透.
- 药理上抑制eIF4F复合体的形成,减少了心脏病发作的大小,改善了心脏功能.
结论:
- 通过mTORC1/eIF4F调节的mRNA转化驱动心脏炎症和单细胞透.
- 这一轴的暂时抑制减轻心肌炎症并改善心脏功能.
- 针对翻译启动为I/R损伤提供了一个有前途的治疗策略.
相关概念视频
01:26Heart Failure Drugs: Inotropic Agents
2.0K
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
2.0K
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
1.9K
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
1.9K
01:16Antianginal Drugs: Nitrates and β-Blockers
1.9K
In cardiovascular health, antianginal drugs combat angina pectoris — a condition marked by chest pain owing to diminished blood flow to the heart.
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
1.9K
01:21Myocarditis I: Introduction
645
Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
645
01:14Myocarditis III: Medical Management
343
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
343
01:26Transient Ischemic Attack l: Introduction
18
A transient ischemic attack (TIA) is a brief episode of neurological dysfunction caused by a temporary, focal reduction in cerebral blood flow. Although symptoms resemble those of an ischemic stroke, the interruption in perfusion is short-lived and does not cause permanent infarction. TIAs are clinically important because they often serve as early warning events for future stroke.Mechanisms of Transient Cerebral IschemiaTransient cerebral ischemia may arise through several mechanisms. One...
18